APAdrienne Pruitt

Adrienne Pruitt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrienne Pruitt has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Anupha M. Mathew

    Clinical Pharmacy Resident, Medical University of South Carolina Health, Charleston, South Carolina

    1 shared publication
  • Clinton A. Ross

    Pharmacy Manager, Medical University of South Carolina, Charleston, South Carolina

    1 shared publication
  • Erin Renae Weeda

    School of Medicine Greenville, University of South Carolina, Greenville, SC, USA

    1 shared publication
  • Sophie Robert

    Clinical Pharmacy Specialist - Psychiatry, Medical University of South Carolina Health, Charleston, South Carolina; Research Assistant Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina; Adjunct Assistant Professor, Medical University of South Carolina, College of Pharmacy, Charleston, South Carolina

    1 shared publication

Latest Publications

  • Open Access

    Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population

    by Anupha M. Mathew, Sophie Robert, Clint Ross, Erin Weeda, Adrienne Pruitt

    This study aimed to compare the rates of agitation-related interventions associated with initial holding versus continuation of home stimulant(s) in a child and adolescent population at the time of admission to an inpatient psychiatric facility. This retrospective chart review included patients less than 18 years of age who were admitted to an academic medical center between July 1, 2017, and July 1, 2018. Patients were divided into 2 groups: those continued on their home stimulant(s) and those who had them held. We compared both groups on agitation-related outcomes by examining the difference in the number of level I or II events or as-needed medication administrations. Mechanical restraints and closed-door seclusions were grouped as level I events, and level II events consisted of nonmechanical restraint. The analysis included 169 patients. In total, 126 (75%) patients were continued on their home stimulant, and 43 (25%) had them held. The occurrence of the composite endpoint of level I or II events or as-needed intramuscular medication administration was numerically higher in the group that had their home stimulant held (27.9% vs 23%; P = .52). Level I events were also numerically higher but not statistically significant in the group that had their home stimulant held (16.3% vs 11.9%; P = .46). The composite outcome of as-needed intramuscular medication administration and level I or II events was numerically higher in the group that had their home stimulant held. Use of a larger sample size and adjusted analyses may help elucidate covariates that impact agitation-related outcomes.